Remnant-like Lipoprotein Particles Impair Endothelial Function: Direct and Indirect Effects on Nitric Oxide Synthase
Xiao-Yan Zheng,Ling Liu
DOI: https://doi.org/10.1194/jlr.r700001-jlr200
IF: 6.676
2007-01-01
Journal of Lipid Research
Abstract:Remnant-like lipoprotein particles (RLPs) have been implicated as potentially atherogenic lipoproteins. Endothelial dysfunction is known to be an early event in atherosclerosis and an important contributor to the pathogenesis of coronary artery disease. Moreover, there is considerable evidence linking increased RLP cholesterol levels with endothelial dysfunction, reflected by impaired endothelial vasodilatation and abnormal endothelial secretion. The underlying mechanisms by which RLPs may contribute to endothelial dysfunction are complex and have not been completely elucidated. Because the expression and activation of endothelial nitric oxide synthase (eNOS) are vital to endothelial function, and recent data have implied an association between RLPs and eNOS, this manuscript proposes the hypothesis that RLPs could impair endothelial function via direct and indirect effects on eNOS: RLPs may affect the autophosphorylation of focal adhesion kinase and its downstream phosphatidylinositol kinase/Akt (protein kinase B) signaling pathway, resulting in eNOS inactivation through induction of intracellular oxidative stress in endothelial cells; and RLPs could affect the expression or activation of eNOS indirectly by stimulating secretion of various inflammatory factors from multiple origins. The practical applications of this manuscript provide new insights for the future investigation of RLPs. Remnant-like lipoprotein particles (RLPs) have been implicated as potentially atherogenic lipoproteins. Endothelial dysfunction is known to be an early event in atherosclerosis and an important contributor to the pathogenesis of coronary artery disease. Moreover, there is considerable evidence linking increased RLP cholesterol levels with endothelial dysfunction, reflected by impaired endothelial vasodilatation and abnormal endothelial secretion. The underlying mechanisms by which RLPs may contribute to endothelial dysfunction are complex and have not been completely elucidated. Because the expression and activation of endothelial nitric oxide synthase (eNOS) are vital to endothelial function, and recent data have implied an association between RLPs and eNOS, this manuscript proposes the hypothesis that RLPs could impair endothelial function via direct and indirect effects on eNOS: RLPs may affect the autophosphorylation of focal adhesion kinase and its downstream phosphatidylinositol kinase/Akt (protein kinase B) signaling pathway, resulting in eNOS inactivation through induction of intracellular oxidative stress in endothelial cells; and RLPs could affect the expression or activation of eNOS indirectly by stimulating secretion of various inflammatory factors from multiple origins. The practical applications of this manuscript provide new insights for the future investigation of RLPs. acetylcholine apolipoprotein E coronary artery disease C-reactive protein endothelium-dependent vasorelaxation endothelial nitric oxide synthase focal adhesion kinase flow-mediated endothelium-dependent dilatation human umbilical vein endothelial cell intercellular adhesion molecule-1 interleukin-1 nitric oxide oxidized LDL remnant-like lipoprotein particle RLP-cholesterol tumor necrosis factor-α vascular cell adhesion molecule-1 Remnant-like lipoprotein particles (RLPs), also known as remnant lipoproteins or remnant-like particles, are derived from VLDLs and chylomicrons, which are the major carriers of plasma triglycerides. The actions of lipoprotein lipase and cholesteryl ester transfer protein on VLDL and chylomicrons produce RLPs with decreased triglyceride and increased cholesteryl ester and apolipoprotein E (apoE). Compared with the nascent triglyceride-rich lipoproteins, RLPs are smaller particles, with a higher density and more cholesteryl ester, which seems to give them more potential atherogenic properties. RLPs have been separated on the basis of their size, density, charge, specific lipid components, or apolipoprotein composition. The analytical “gold standard” for measuring triglyceride-rich lipoproteins and remnants is density gradient ultracentrifugation; however, this technique is labor-intensive and involves a 24 h analysis to fractionate the plasma lipoproteins. Moreover, only a few samples can be processed at the same time in each ultracentrifuge. Tsai et al. (1.Tsai M.Y. Georgopoulos A. Otvos J.D. Ordovas J.M. Hanson N.Q. Peacock J.M. Arnett D.K. Comparison of ultracentrifugation and nuclear magnetic resonance spectroscopy in the quantification of triglyceride-rich lipoproteins after an oral fat load.Clin. Chem. 2004; 50: 1201-1204Crossref PubMed Scopus (39) Google Scholar) used NMR spectroscopy to perform numerous postprandial analyses of triglyceride-rich lipoproteins in a large interventional study, and observed that chylomicrons and chylomicron remnants/VLDL fraction measurements obtained by NMR had a high degree of correlation with results produced by ultracentrifugation. NMR is a more rapid procedure and uses substantially less sample volume than traditional ultracentrifugation. And NMR is a physical procedure, so that plasma samples can be preserved for biochemical assays of stable analytes. However, NMR is a relatively expensive method, with a special analyzer, and is not widely available in clinical laboratories at present. Recently, a novel immunoseparation method for RLPs has been developed (2.Nakajima K. Saito T. Tamura A. Suzuki M. Nakano T. Adachi M. Tanaka A. Tada N. Nakamura H. Campos E. Cholesterol in remnant-like lipoproteins in human serum monoclonal anti apo B-100 and anti apo A-1 immunoaffinity mixed gels.Clin. Chim. Acta. 1993; 223: 53-71Crossref PubMed Scopus (412) Google Scholar). This method uses two monoclonal antibodies, to human apoB-100 and apoA-I, respectively, to remove most of the apoB-100-containing lipoproteins (namely, LDLs and nascent VLDLs) and apoA-I-containing lipoproteins (namely chylomicrons and HDLs), leaving behind an unbound fraction including VLDL remnants containing apoB-100 and chylomicron remnants containing apoB-48, both of which are enriched in apoE. Characterization of the unbound lipoproteins of d < 1.006 g/ml has shown that they represent RLPs. The reason that the anti-apoB-100 antibody does not recognize the apoB-100 of apoE-enriched VLDL remnants is not entirely clear, although the amino acid sequence of the apoB-100 epitope region has been found to be homologous to an amphipathic helical region of apoE, suggesting that apoE can compete for binding of the antibody to its epitope on apoB-100 (3.Nakajima K. Okazaki M. Tanaka A. Pullinger C.R. Wang T. Nakano T. Adachi M. Havel R.J. Separation and determination of remnant-like particles in human serum using monoclonal antibodies to apoB-100 and apo AI.J. Clin. Lig. Assay. 1996; 19: 177-183Google Scholar). Cholesterol in RLPs (RLP-C) is measured by a sensitive enzyme assay. In comparison with the ultracentrifugation, NMR, and nondenaturing polyacrylamide gel electrophoresis methods, the RLP-C assay has higher specificity, sensitivity, and throughput, as well as lower complexity, which makes it applicable for routine analysis in clinical laboratories. There is considerable evidence linking increased plasma RLP-C levels with coronary artery disease (CAD). A growing body of studies suggests that RLP-C levels are markedly higher in CAD patients compared with healthy control subjects (4.Leary E.T. Wang T. Baker D.J. Cilla D.D. Zhong J. Warnick G.R. Nakajima K. Havel R.J. Evaluation of an immunoseparation method for quantitative measurement of remnant-like particle-cholesterol in serum and plasma.Clin. Chem. 1998; 44: 2490-2498Crossref PubMed Google Scholar, 5.Devaraj S. Vega G. Lange R. Grundy S.M. Jialal I. Remnant-like particle cholesterol levels in patients with dysbetalipoproteinemia and coronary artery disease.Am. J. Med. 1998; 104: 445-450Abstract Full Text Full Text PDF PubMed Scopus (86) Google Scholar). The most dramatic demonstration of the atherogenic potential of RLPs is observed in type III hyperlipoproteinemia (familial dysbetalipoproteinemia), where xanthoma formation and atherosclerosis can be extensive (6.Rall S.C. Mahley R.W. The role of apolipoprotein E genetic variants in lipoprotein disorders.J. Intern. Med. 1992; 231: 653-659Crossref PubMed Scopus (135) Google Scholar). RLP-C levels have been found to be significantly elevated in patients with this disease. The molecular defect in type III hyperlipoproteinemia is the presence of a mutant form of apoE, which is defective in binding to both apoB and apoE receptors, resulting in an impaired clearance of RLPs (7.Mahley R.W. Innerarity T.L. Rall S.C. Weisgraber K.H. Lipoproteins of special significance in atherosclerosis. Insights provided by studies of type III hyperlipoproteinemia.Ann. N. Y. Acad. Sci. 1985; 454: 209-221Crossref PubMed Scopus (55) Google Scholar). ApoE knockout mice develop extensive atherosclerosis and have become one of the most widely used animal models for exploring atherogenesis in vivo (8.Zhang S.H. Reddick R.L. Piedrahita J.A. Maeda N. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E.Science. 1992; 258: 468-471Crossref PubMed Scopus (1841) Google Scholar). It is thought that RLPs that accumulate in plasma of these mice are atherogenic and induce foam cell formation. These studies strongly demonstrate the potential adverse effects of RLPs on atherosclerosis. Atherosclerosis is thought to begin with the trapping of cholesterol-rich lipoproteins within the intima of arterial vessels. In the past, chylomicrons were not normally considered to be directly involved in atherogenesis, because of their larger size and inability to efficiently penetrate arterial tissue. However, there is accumulating evidence that suggests that once chylomicrons are hydrolyzed to their remnants form, the triglyceride-depleted chylomicron remnants penetrate arterial tissue and, moreover, become preferentially trapped within the subendothelial space as concentrated focii. Ongoing studies demonstrate that significant chylomicron remnant accumulation can occur in a number of primary and secondary lipid disorders and in normolipidemic subjects with CAD (9.Mamo J.C.L. Proctor S.D. Smith D. Retention of chylomicron remnants by arterial tissue; importance of an efficient clearance mechanism from plasma.Atherosclerosis. 1998; 141: 63-69Abstract Full Text Full Text PDF PubMed Scopus (90) Google Scholar). Moreover, chylomicron remnants have been shown to accumulate in both the rabbit and rat aorta in vivo (10.Mamo J.C.L. Wheeler J.R. Chylomicrons or their remnants penetrate rabbit thoracic aorta as efficiently as do smaller macromolecules, including low-density lipoprotein, high-density lipoprotein, and albumin.Coron. Artery Dis. 1994; 5: 695-705Crossref PubMed Scopus (97) Google Scholar – 12.Proctor S.D. Pabla C.K. Mamo J.C.L. Arterial uptake of chylomicrons and low density lipoproteins in insulin deficient rats and rabbits.Atherosclerosis. 1997; 134: 314Abstract Full Text PDF Google Scholar), and apoE-containing lipoproteins have been found in the human aortic intima (13.Yla-Herttuala S. Jaakkola O. Ehnholm C. Tikkanen M.J. Solakivi T. Sarkioja T. Nikkari T. Characterization of two lipoproteins containing apolipoproteins B and E from lesion-free human aortic intima.J. Lipid Res. 1988; 29: 563-572Abstract Full Text PDF PubMed Google Scholar). These studies provide evidence that the arterial retention of RLPs may pose a significant atherogenic risk. As relatively smaller remnants particles and considering the close relationship between VLDL and LDL, remnants derived from VLDL could be more atherogenic than chylomicron remnants. The endothelium, formed by the monolayer of endothelial cells, is not a passive blood-compatible lining for the containment of blood cells and plasma, but rather a metabolically active tissue that subserves a wide range of functions relating to vascular homeostasis. Endothelial cells play an important role in the control of vasomotor tone, permeability, coagulation, growth of vascular smooth muscle cells, and inflammatory responses by releasing or expressing various factors (14.Jeremy D.P. Endothelial cell biology.Radiology. 1991; 179: 9-14Crossref PubMed Scopus (48) Google Scholar, 15.Shireman P.K. Pearce W.H. Endothelial cell function: biologic and physiologic functions in health and disease.AJR. Am. J. Roentgenol. 1996; 166: 7-13Crossref PubMed Scopus (33) Google Scholar). A balanced release of these bioactive factors facilitates vascular homeostasis. Endothelial dysfunction disrupts this balance, thereby predisposing the vessel wall to vasoconstriction, leukocyte adherence, platelet activation, mitogenesis, pro-oxidation, thrombosis, impaired fibrinolytic function, vascular inflammation, and finally, atherosclerosis (16.Subodh V. Todd J.A. Fundamentals of endothelial function for the clinical cardiologist.Circulation. 2002; 105: 546-549Crossref PubMed Scopus (512) Google Scholar). Assessment of endothelial cell function refers to a measure of endothelial cell response to stimulation, for example, by vasoactive substances released by or those that interact with the vascular endothelium. Endothelium-dependent vasorelaxation (EDR) can be assessed in the coronary and peripheral circulations in humans (17.Farouque H.M. Meredith I.T. The assessment of endothelial function in humans.Coron. Artery Dis. 2001; 12: 445-454Crossref PubMed Scopus (34) Google Scholar). Quantitative coronary angiography has been used to measure coronary vasomotor responses, and more recently, ultrasound has been used as a noninvasive measurement of endothelial function, especially when examining brachial arteries. At present, brachial artery ultrasound is widely used to assess vasomotor function. Importantly, EDR assessed by this technique in peripheral artery closely correlates with coronary EDR (18.Anderson T.J. Uehata A. Gerhard M.D. Meredith I.T. Knab S. Delagrange D. Lieberman E.H. Ganz P. Creager M.A. Yeung A.C. Close relation of endothelial function in the human coronary and peripheral circulations.J. Am. Coll. Cardiol. 1995; 26: 1235-1241Crossref PubMed Scopus (1761) Google Scholar). Because endothelial dysfunction is known to be an early event in atherosclerosis and an important contributor to the pathogenesis of CAD (19.Yasue H. Matsuyama K. Matsuyama K. Okumura K. Morikami Y. Ogawa H. Responses of angiographically normal human coronary arteries to intracoronary injection of acetylcholine by age and segment. Possible role of early coronary atherosclerosis.Circulation. 1990; 81: 482-490Crossref PubMed Scopus (302) Google Scholar, 20.Zeiher A.M. Drexler H. Saurbrier B. Just H. Endothelium-mediated coronary blood flow modulation in humans: effects of age, atherosclerosis, hypercholesterolemia, and hypertension.J. Clin. Invest. 1993; 92: 652-662Crossref PubMed Scopus (629) Google Scholar), the present article focuses on the association between RLPs and endothelial dysfunction, and the potential underlying mechanisms by which RLPs may contribute to endothelial dysfunction. In the following segment, endothelial dysfunction will be discussed with two aspects: 1) abnormal endothelial cell secretion and 2) impaired EDR. In the inflammatory and proliferative responses of the endothelium, some adhesion molecules, including vascular cell adhesion molecule-1 (VCAM-1), intercellular adhesion molecule-1 (ICAM-1), and E-selectin, are expressed by the activated endothelial cells in the atherosclerotic lesions (21.Reape T.J. Groot P.H. Chemokines and atherosclerosis.Atherosclerosis. 1999; 147: 213-225Abstract Full Text Full Text PDF PubMed Scopus (432) Google Scholar), and chemokines such as monocyte chemoattractant protein-1 and cytokines such as interleukin-1 (IL-1) and tumor necrosis factor-α (TNF-α) are also secreted by the endothelial cells (22.Adams D.H. Shaw S. Leucocyte-endothelial interactions and regulation of leucocyte migration.Lancet. 1994; 343: 831-836Abstract PubMed Scopus (567) Google Scholar). There is increasing evidence that RLPs can induce various inflammatory factors derived from endothelial cells. Upon incubation of human umbilical vein endothelial cells (HUVECs) with RLPs (50 μg/ml), adherent monocytes significantly increased by 3.3-fold, with increased cell surface expression of VCAM-1, ICAM-1, E-selectin, and monocyte chemoattractant protein-1 (23.Park S.Y. Lee J.H. Kim Y.K. Kim C.D. Rhim B.Y. Lee W.S. Hong K.W. Cilostazol prevents remnant lipoprotein particle-induced monocyte adhesion to endothelial cells by suppression of adhesion molecules and monocyte chemoattractant protein-1 expression via lectin-like receptor for oxidized low-density lipoprotein receptor activation.J. Pharmacol Exp. Ther. 2005; 312: 1241-1248Crossref PubMed Scopus (74) Google Scholar). Doi et al. (24.Doi H. Kugiyama K. Oka H. Sugiyama S. Ogata N. Koide S. Nakamura S. Yasue H. Remnant lipoproteins induce proatherothrombogenic molecules in endothelial cells through a redox-sensitive mechanism.Circulation. 2000; 102: 670-676Crossref PubMed Scopus (167) Google Scholar) also found that RLPs (0.1 mg cholesterol/ml) upregulated endothelial expression of ICAM-1 and VCAM-1. Shin et al. (25.Shin H.K. Kim Y.K. Kim K.Y. Lee J.H. Hong K.W. Remnant lipoprotein particles induce apoptosis in endothelial cells by NAD(P)H oxidase–mediated production of superoxide and cytokines via lectin-like oxidized low-density lipoprotein receptor-1 activation: prevention by cilostazol.Circulation. 2004; 109: 1022-1028Crossref PubMed Scopus (212) Google Scholar) reported that RLPs (50 μg/ml) significantly increased superoxide formation in HUVECs, associated with increased production of TNF-α and IL-1β, and cell death. In addition, RLPs effect endothelial expression of plasminogen activator inhibitor-1. In studies incubating human aortic endothelial cells with RLPs, Sawka et al. (26.Sawka A.M. Singh R.J. Hiddinga H.J. McConnell J.P. Eberhardt N.L. Caplice N.M. O'Brien T. Remnant lipoproteins induce endothelial plasminogen activator inhibitor-1.Biochem. Biophys. Res. Commun. 2001; 285: 15-19Crossref PubMed Scopus (11) Google Scholar) demonstrated that RLPs from patients with type III hyperlipoproteinemia induced endothelial cell plasminogen activator inhibitor-1 expression, which may contribute to a prothrombotic state. Likewise, RLPs upregulate endothelial expression of tissue factor, which is essential for thrombotic events, in the same range of RLP concentrations as in peripheral plasma in patients with CAD (24.Doi H. Kugiyama K. Oka H. Sugiyama S. Ogata N. Koide S. Nakamura S. Yasue H. Remnant lipoproteins induce proatherothrombogenic molecules in endothelial cells through a redox-sensitive mechanism.Circulation. 2000; 102: 670-676Crossref PubMed Scopus (167) Google Scholar). Evidence is accumulating that these RLP-stimulated effects are dependent on the activation of lectin-like oxidized LDL receptor-1 (LOX-1), a vascular endothelial receptor for oxidized LDL (Ox-LDL). Ox-LDL has been widely believed to play a key role in the initiation and progression of atherosclerosis since Steinberg et al. (27.Steinberg D. Parthasarathy S. Crew T.E. Khoo J.C. Witztum J.L. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenecity.N. Engl. J. Med. 1989; 320: 915-924PubMed Google Scholar) proposed the Ox-LDL hypothesis as the major cause of atherosclerosis. Monoclonal antibodies to LOX-1 and antisense LOX-1 oligodeoxynucleotide significantly reduced these RLP-mediated effects (23.Park S.Y. Lee J.H. Kim Y.K. Kim C.D. Rhim B.Y. Lee W.S. Hong K.W. Cilostazol prevents remnant lipoprotein particle-induced monocyte adhesion to endothelial cells by suppression of adhesion molecules and monocyte chemoattractant protein-1 expression via lectin-like receptor for oxidized low-density lipoprotein receptor activation.J. Pharmacol Exp. Ther. 2005; 312: 1241-1248Crossref PubMed Scopus (74) Google Scholar, 25.Shin H.K. Kim Y.K. Kim K.Y. Lee J.H. Hong K.W. Remnant lipoprotein particles induce apoptosis in endothelial cells by NAD(P)H oxidase–mediated production of superoxide and cytokines via lectin-like oxidized low-density lipoprotein receptor-1 activation: prevention by cilostazol.Circulation. 2004; 109: 1022-1028Crossref PubMed Scopus (212) Google Scholar). LOX-1 protein was demonstrated to mediate apoptotic cell death in endothelial cells (28.Li D. Mehta J.L. Antisense to LOX-1 inhibits oxidized LDL-mediated upregulation of monocyte chemoattractant protein-1 and monocyte adhesion to human coronary artery endothelial cells.Circulation. 2000; 101: 2889-2895Crossref PubMed Scopus (376) Google Scholar). Shin et al. (25.Shin H.K. Kim Y.K. Kim K.Y. Lee J.H. Hong K.W. Remnant lipoprotein particles induce apoptosis in endothelial cells by NAD(P)H oxidase–mediated production of superoxide and cytokines via lectin-like oxidized low-density lipoprotein receptor-1 activation: prevention by cilostazol.Circulation. 2004; 109: 1022-1028Crossref PubMed Scopus (212) Google Scholar) have emphasized the importance of RLPs in increasing the expression of LOX-1 receptor protein in NADPH oxidase-dependent superoxide production associated with DNA fragmentation and apoptotic cell death in HUVECs. Isolated RLPs were found to be oxidized or to be susceptible to oxidation in plasma. A new oxidative modification hypothesis has been proposed that postulates that RLPs, not LDL, are the major oxidized lipoproteins in plasma, based on observations of the plasma concentration of these oxidized lipoproteins. Many studies have shown that the concentration of Ox-LDL in plasma is less than 0.5% of total LDL in CAD patients. The most significant role of Ox-LDL in atherogenesis may be played in the subendothelial space with interactions with macrophages and smooth muscle cells, not in endothelial cells. It is conjectured that RLPs, not Ox-LDL in plasma, are the major ligand for the LOX-1 receptor in endothelial cells, causing endothelial dysfunction and the initiation of atherosclerosis (29.Nakajima K. Nakano T. Tanaka A. The oxidative modification hypothesis of atherosclerosis: the comparison of atherogenic effects on oxidized LDL and remnant lipoproteins in plasma.Clin. Chim. Acta. 2006; 367: 36-47Crossref PubMed Scopus (149) Google Scholar). There is accumulating evidence that suggests that RLP-C levels have an inverse and independent correlation with EDR. It is known that acetylcholine (ACh)-induced vasodilatation is mediated by nitric oxide (NO) released from the endothelium (30.Furchgott R.F. Zawadzki J.V. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine.Nature. 1980; 288: 373-376Crossref PubMed Scopus (9994) Google Scholar), which diffuses to the underlying smooth muscle cells to cause relaxation. The arterial response to ACh is determined by the balance between endothelium-derived NO and the direct constrictor action of ACh on smooth muscle. Hence, impaired ACh-induced relaxation reflects endothelial dysfunction. In this connection, Inoue et al. (31.Inoue T. Saniabadi A.R. Matsunaga R. Hoshi K. Yaguchi I. Morooka S. Impaired endothelium-dependent acetylcholine-induced coronary artery relaxation in patients with high serum remnant lipoprotein particles.Atherosclerosis. 1998; 139: 363-367Abstract Full Text Full Text PDF PubMed Scopus (51) Google Scholar) reported that ACh induced coronary artery spasm in patients with elevated serum RLP-C levels, an effect that was not observed in the coronary arteries of patients with low or normal serum RLP-C levels. Kugiyama et al. (32.Kugiyama K. Doi H. Motoyama T. Soejima H. Misumi K. Kawano H. Nakagawa O. Yoshimura M. Ogawa H. Matsumura T. et al.Association of remnant lipoprotein levels with impairment of endothelium-dependent vasomotor function in human coronary arteries.Circulation. 1998; 97: 2519-2526Crossref PubMed Scopus (171) Google Scholar) also reported that compared with LDL-cholesterol, age, and smoking history, RLP-C levels had the most significant correlation with abnormal epicardial coronary vasomotor responses to ACh infusion, reflected by impaired dilation or constriction of the epicardial coronary arteries. Further, in a subgroup of 53 consecutive subjects, constrictor responses of epicardial coronary diameters to intracoronary infusion at baseline of NG-monomethyl-l-arginine, an inhibitor of NO synthase, reflecting the presence of coronary NO bioactivity, had an inverse and independent correlation with RLP-C levels, shown by use of multivariate analysis (32.Kugiyama K. Doi H. Motoyama T. Soejima H. Misumi K. Kawano H. Nakagawa O. Yoshimura M. Ogawa H. Matsumura T. et al.Association of remnant lipoprotein levels with impairment of endothelium-dependent vasomotor function in human coronary arteries.Circulation. 1998; 97: 2519-2526Crossref PubMed Scopus (171) Google Scholar). It is suggested that the decrease in coronary NO bioactivity may be responsible in part for the inhibitory effects of RLPs. Consistent with these findings, it has been demonstrated that elevated RLP-C levels were correlated with the impairment of ACh-induced coronary artery response in patients with high insulin resistance but without angiographically significant CAD (33.Inoue T. Uchida T. Kamishirado H. Sakuma M. Sakai Y. Takayanagi K. Hayashi T. Morooka S. Possible relationship between insulin resistance and remnant-like lipoprotein particles in coronary endothelial dysfunction.Clin. Cardiol. 2002; 25: 532-536Crossref PubMed Scopus (6) Google Scholar). Furthermore, Funada et al. (34.Funada J. Sekiya M. Otani T. Watanabe K. Akutsu H. Impact of high remnant-like lipoproteins on the function of peripheral arterial endothelium in patients with hyperlipidemia and normolipidemia: estimation using Doppler flow analysis.J. Cardiol. 2001; 37: 267-276PubMed Google Scholar) reported that the brachial artery response after the administration of ACh (50 μg) was significantly less in patients with high RLP-C levels than in patients with low RLP-C levels, indicating that RLP-C is an independent lipid factor that regulates peripheral vascular endothelial functions even in normolipidemic patients. Measurement of flow-mediated brachial artery vasoactivity using high-resolution ultrasonography has been reported as an accurate and sensitive method for detecting endothelial dysfunction. The forearm blood flow is occluded for 5 min using a blood pressure cuff maintained at a standard pressure. When the pressure is released, reactive hyperemia occurs. This results in shear stress-induced NO release and subsequent vasodilatation. Using this technique, Nakamura et al. (35.Nakamura T. Takano H. Umetani K. Kawabata K. Obata J. Kitta Y. Kodama Y. Mende A. Ichigi Y. Fujioka D. et al.Remnant lipoproteinemia is a risk factor for endothelial vasomotor dysfunction and coronary artery disease in metabolic syndrome.Atherosclerosis. 2005; 181: 321-327Abstract Full Text Full Text PDF PubMed Scopus (73) Google Scholar) reported that elevated fasting RLP-C level was a significant and independent risk factor for impaired flow-mediated endothelium-dependent dilatation (FMD) and angiographically proven CAD in 210 patients with metabolic syndrome. It is worth noting that the postprandial state occurs for more than 12 h daily in most individuals, so the postprandial triglyceride-rich lipoproteins and remnants may play a more important role in atherogenesis than the fasting profiles (36.Funada J. Sekiya M. Hamada M. Hiwada K. Postprandial elevation of remnant lipoprotein leads to endothelial dysfunction.Circ. J. 2002; 66: 127-132Crossref PubMed Scopus (39) Google Scholar). Plotnick, Corretti, and Vogel (37.Plotnick G.D. Corretti M.C. Vogel R.A. Effect of antioxidant vitamins on the transient impairment of endothelium-dependent brachial artery vasoactivity following a single high-fat meal.J. Am. Med. Assoc. 1997; 278: 1682-1686Crossref PubMed Google Scholar) observed that a single high-fat meal transiently reduced endothelial function for up to 4 h in healthy, normocholesterolemic subjects, whereas there was no significant change in FMD after a low-fat meal. The change in FMD after low-fat and high-fat meals was inversely correlated with the 2 h postprandial change in triglyceride levels. Several studies have also demonstrated the relationship between postprandial RLPs and endothelial dysfunction, determined as a marked impairment of FMD (36.Funada J. Sekiya M. Hamada M. Hiwada K. Postprandial elevation of remnant lipoprotein leads to endothelial dysfunction.Circ. J. 2002; 66: 127-132Crossref PubMed Scopus (39) Google Scholar, 38.Maggi F.M. Raselli S. Grigore L. Redaelli L. Fantappie S. Catapano A.L. Lipoprotein remnants and endothelial dysfunction in the postprandial phase.J. Clin. Endocrinol. Metab. 2004; 89: 2946-2950Crossref PubMed Scopus (64) Google Scholar). These findings suggest that repeated increases in postprandial RLPs in the circulation might impair EDR even in individuals with normal fasting lipids levels. Several animal experiments ex vivo have been done to explore the effects of remnants on EDR and the involved mechanisms. Doi et al. (39.Doi H. Kugiyama K. Ohgushi M. Sugiyama S. Matsumura T. Ohta Y. Nakano T. Nakajima K. Yasue H. Remnants of chylomicron and very low density lipoprotein impair endothelium-dependent vasorelaxation.Atherosclerosis. 1998; 137: 341-349Abstract Full Text Full Text PDF PubMed Scopus (116) Google Scholar) found that RLPs obtained from hyperlipidemic patients who complained of chest pain attenuated ACh-induced EDR in isolated rabbit aorta. A similar inhibition of EDR was subsequently reported by Ohara et al. (40.Ohara N. Takeichi S. Naito Y. Nakajima Y. Yukawa N. Nakano T. Nakajima K. Remnant-like particles from subjects who died of coronary artery disease suppress NO synthase activity and attenuate endothelium-dependent vasorelaxation.Clin